Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Neonicotinoids research uncovered by FOI request
honey bees
However, the studies have been criticised for focusing solely on honeybees, when research has shown wild bees may be at greater risk from neonicotinoids.
Pesticide manufacturers' research shows harm to bees
 
Studies commissioned by Bayer and Syngenta have shown their own neonicotinoid pesticides can cause serious harm to honeybees, a freedom of information (FOI) request has revealed.

The research findings were obtained by Greenpeace from the US environmental regulator. The studies, which were designed with regulators, focused on Bayer's clothianidin and Syngenta's thiamethoxam.

Greenpeace Energydesk is not allowed to release the studies in full due to commercial confidentiality rules, but both studies showed the pesticides can seriously harm honeybees at high concentrations (50 parts per billion - ppb). The effects are less marked at lower levels of 40 ppb.

The companies responded by saying that while the studies did show a risk to honeybees, this only applied at higher concentrations than would normally be seen in agriculture.

Responding to Energydesk's story, a spokesperson for Bayer said: "Based on these results, we believe the data support the establishment of a no-effect concentration of 20 ppb for clothianidin, which is consistent to that of other neonicotinoids."

A Syngenta spokesperson added: "There were transient effects observed and the reported No Adverse Effect Level (NOAEL) for this study was 50 ppb. It is accepted that residues of thiamethoxam in pollen and nectar from seed treated crops are in the single ppb level. So this reported NOAEL of 50 ppb indicates that honey bee colonies are at low risk from exposure to thiamethoxam in pollen and nectar of seed treated crops."

However, the studies have been criticised for focusing solely on honeybees, when research has shown wild bees may be at greater risk from neonicotinoids. As a result, Greenpeace Energydesk said in a statement that the studies may substantially underestimate the impact of these chemicals on pollinators.

Conservationists have also found fault with the narrow definition of harm to honeybee health and fact that the studies were not conducted in 'normal' field conditions - bee colonies were fed a spiked sugar solution.

Matt Shadlow, chief executive of the charity Buglife, told the Guardian: "These studies may not show an impact on honeybee health [at low levels], but then the studies are not realistic. The bees were not exposed to the neonics that we know are in planting dust, water drunk by bees and wildflowers, wherever neonics are used as seed treatments. This secret evidence highlights the profound weakness of regulatory tests."

The revelation has prompted calls for greater transparency from the industry and regulators. Christian Krupke, an entomologist at Purdue University, said: "Bayer and Syngenta’s commitment to pollinator health should include publishing these data or otherwise making them public. This work presents a rich dataset that could greatly benefit the many publicly funded scientists examining the issue worldwide, including avoiding costly and unnecessary duplication of research."

According to Bayer, the research will be presented next week at the Congress of Entomology in Orlando, while Syngenta says their study is in the process of being published in a journal.

The US Environmental Protection Agency (EPA) is currently reviewing the impact of neonicotinoids. Early this year, stage one of the review found imidacloprid, which is made by Bayer, harmed honeybees. Its findings on clothianidin and thiamethoxam are due to be published in 2017.

 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.